Leukemia, 2022-11, Vol.36 (11), p.2739-2742
- Mekinian, Arsene
- Zhao, Lin Pierre
- Chevret, Sylvie
- Desseaux, Kristell
- Pascal, Laurent
- Comont, Thibaut
- Maria, Alexandre
- Peterlin, Pierre
- Terriou, Louis
- D’Aveni Piney, Maud
- Gourin, Marie-Pierre
- Vey, Norbert
- Rauzy, Odile Beyne
- Grobost, Vincent
- Bezanahary, Holy
- Dimicoli-Salazar, Sophie
- Banos, Anne
- Wickenhauser, Stefan
- De Renzis, Benoit
- Durot, Eric
- Natarajan-Amé, Shanti
- Voillat, Laurent
- Chermat, Fatiha
- Lemaire, Karine
- Jachiet, Vincent
- Himberlin, Chantal
- Thépot, Sylvain
- Diaz, Jose Miguel Torregrosa
- Frenzel, Laurent
- Gyan, Emmanuel
- Denis, Guillaume
- Hirsch, Pierre
- Kosmider, Olivier
- Ades, Lionel
- Fain, Olivier
- Fenaux, Pierre
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Mekinian, Arsene
- Zhao, Lin Pierre
- Chevret, Sylvie
- Desseaux, Kristell
- Pascal, Laurent
- Comont, Thibaut
- Maria, Alexandre
- Peterlin, Pierre
- Terriou, Louis
- D’Aveni Piney, Maud
- Gourin, Marie-Pierre
- Vey, Norbert
- Rauzy, Odile Beyne
- Grobost, Vincent
- Bezanahary, Holy
- Dimicoli-Salazar, Sophie
- Banos, Anne
- Wickenhauser, Stefan
- De Renzis, Benoit
- Durot, Eric
- Natarajan-Amé, Shanti
- Voillat, Laurent
- Chermat, Fatiha
- Lemaire, Karine
- Jachiet, Vincent
- Himberlin, Chantal
- Thépot, Sylvain
- Diaz, Jose Miguel Torregrosa
- Frenzel, Laurent
- Gyan, Emmanuel
- Denis, Guillaume
- Hirsch, Pierre
- Kosmider, Olivier
- Ades, Lionel
- Fain, Olivier
- Fenaux, Pierre
- Titel
- A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML
- Ist Teil von
- Leukemia, 2022-11, Vol.36 (11), p.2739-2742
- Ort / Verlag
- London: Nature Publishing Group UK
- Erscheinungsjahr
- 2022
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0887-6924eISSN: 1476-5551DOI: 10.1038/s41375-022-01698-8Titel-ID: cdi_hal_primary_oai_HAL_hal_04510880v1
- Format
- –
- Schlagworte
- 692/420/2780, 692/699/1541/1990/1673, 692/700/565/251, Arthritis, Azacitidine - therapeutic use, Cancer Research, Chronic myelomonocytic leukemia, Critical Care Medicine, Epigenetics, Fever, Hematology, Humans, Inflammatory diseases, Intensive, Internal Medicine, Letter, Leukemia, Leukemia, Myelomonocytic, Chronic - complications, Leukemia, Myelomonocytic, Chronic - drug therapy, Life Sciences, Medical prognosis, Medicine, Medicine & Public Health, Mutation, Myelodysplastic Syndromes - complications, Myelodysplastic Syndromes - drug therapy, Oncology, Prospective Studies, Steroids